All articles
ComplianceNovember 9, 2026·3 min read

How to Write Recruitment Ads That Clear IRB the First Time

IRB rejections of recruitment ads usually come down to a handful of predictable language problems. Here's what reviewers flag, what your ads must include, and how to structure submissions so approvals come faster.

By Trialflow Team

Most recruitment ad rejections aren't about bad intentions. They're about language that drifted toward marketing when it needed to stay in the territory of plain, factual description. Here's how to write ads that clear review the first time and still work.

The core rule nobody states plainly

An IRB treats your advertisement as the first step of the informed consent process. Everything downstream of that follows logically: the ad can't promise anything the consent form doesn't, can't minimize risk, and can't imply that the investigational product works. If you keep that single frame in mind while drafting, you will catch most problems yourself.

What reviewers consistently flag

Efficacy implications. "New treatment that reduces flare-ups" asserts a result. "A research study of an investigational medication for people with frequent flare-ups" does not. Watch adjectives especially — promising, advanced, breakthrough, effective all carry claims.

Free care framing. Study-related care is provided at no cost; it isn't "free medical care." Avoid implying participants get general healthcare. Say "study-related care at no cost to you," and keep it well down the ad rather than in the headline.

Compensation as the hook. Most IRBs allow you to state compensation, but not to emphasize it. Bolded dollar amounts, large fonts, and "EARN UP TO $1,200" headlines invite undue-inducement concerns. Put the figure in body copy, in the same type size as everything else, and describe it as compensation for time and travel.

Coercive urgency. "Last chance," "limited spots," and countdown timers push people toward a decision they should make deliberately. "Enrollment is open through spring" is fine; manufactured scarcity usually isn't.

Implied endorsement. Don't suggest the FDA, your hospital system, or a professional society has reviewed or approved the study beyond what's true. "FDA-approved study" is a common and serious error — the IND is not an approval.

The elements to include

  • Clear statement that this is clinical research
  • The condition being studied
  • Key eligibility criteria in short, scannable form
  • Study location, in general terms
  • Time commitment, if you can state it honestly
  • Contact method and the PI or site name as required by your IRB
  • Any required IRB approval language or protocol number

Practical workflow tips

Submit a family, not a single ad. Rather than approving one flyer, get a template approved with bracketed variables you can swap — city, clinic phone number, appointment windows. Many IRBs will approve a set if you show the full range of versions up front.

Submit every channel at once. Radio script, social post with character limits, waiting-room poster, text message, and the landing page it points to. Reviewers care about the whole path. The ad and the page the ad leads to are evaluated together more often than coordinators expect.

Keep a version log. Record approval date, approved file, which channels it runs on, and expiration. When monitors ask for proof that what ran is what was approved, screenshots of live ads matched to approval letters save hours.

Don't let platforms rewrite you. Social ad tools suggest headline variants and auto-generate copy. Any auto-generated text that goes live is unapproved text. Turn those features off.

The reframe that helps most

Compliant ads aren't weaker ads. Clarity about what the study actually asks of someone tends to attract people who follow through and screen out those who were responding to a promise. Vague, enthusiastic copy fills your phone line with people who thought they were getting treatment.

Enrolling studies shouldn't be this hard

Trialflow gives research sites one platform for lead management, AI trial matching, and recruitment analytics.

Request a Demo